Results indicated that Netrin-1 was significantly enhanced in the serum of MS patients compared to controls and in the blood vessels of perivascular lesions in MS patients and EAE mice, showing increased expressions of Netrin-1 within the brain. The gene discussed is NTN1; the disease is myeloid sarcoma.